CAN_335

origin: Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents.
author: Kovackova, S., Chang, L., Bekerman, E., Neveu, G., Barouch-Bentov, R., Chaikuad, A., Heroven, C., Sa
patent: no
publication_number: not known
patent_application_number: not known
CDR1_seq: TSRMG(predict)
CDR1_length: 5
CDR2_seq: CIHRQSNLSY(predict)
CDR2_length: 10
CDR3_seq: TTDCAAFVERAT(predict)
CDR3_lentgh: 12
protein_seq: QVQLQESGGGSVQAGGSLRLSCGASEYTSRMGWFRQAPGAEREGVACIHRQSNLSYYSDSVRGRFTISQDNAKTTAFLLMSSLKPEDTAIYYCATTTDCAAFVERATAITAGQGTQVTVSSAAAYPYDVPDYGSHHHHHH
DNA_seq: not known
PubMed_ID: 25822739
PDB_ID: 4Y8D
PDB_deposition_date: 2015-02-16
PDB_released_date: 2015-04-08
resolution: 2.1Å
source_organism: Lama glama
experiment_method: llama immunization,library construction,screen,express
antigen: GAK(Cyclin G Associated Kinase)
antigen_chain: not known
antigen_source: not known
antigen_seq: not known
epitope: not known
IEDB_ID: not known
epitope_reference: not known
function: not known
validationORprediction: Experiment Validation
bacteria_family: Escherichia coli
publication: J Med Chem. 2015 Apr 23;58(8):3393-410. doi: 10.1021/jm501759m. Epub 2015 Apr 9.